GMED241220P35000
- 0.00
- 0.000.00%
Globus Medical Newsroom
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $91
Globus Medical Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $95
Wells Fargo Reaffirms Their Buy Rating on Globus Medical (GMED)
Globus Medical Analyst Ratings
Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $92
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $92
Globus Medical Raised to Overweight From Equal-Weight by Morgan Stanley
Globus Medical Analyst Ratings
Morgan Stanley Initiates Globus Medical(GMED.US) With Buy Rating, Announces Target Price $100
JMP Securities Maintains Globus Medical(GMED.US) With Hold Rating
Globus Medical's Strong Q3 Performance and Conservative Outlook Justify Hold Rating Amid Merger Challenges
Morgan Stanley Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $83
Globus Medical Analyst Ratings
Barclays Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Stifel Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $85 to $100
Globus Medical Price Target Raised to $100.00/Share From $80.00 by Piper Sandler
Globus Medical Is Maintained at Overweight by Piper Sandler